Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.
复制标题
DOI:
10.1161/circresaha.109.216101
复制
发表时间:
2010-08-06
影响因子:
20.1
通讯作者:
Frangogiannis NG
中科院分区:
文献类型:
--
作者:
Dobaczewski M;Bujak M;Li N;Gonzalez-Quesada C;Mendoza LH;Wang XF;Frangogiannis NG
Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming Growth Factor (TGF)-βSmad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. Our study explores the mechanisms responsible for the fibrogenic effects of Smad3 by dissecting its role in modulating cardiac fibroblast phenotype and function. Smad3 null mice and corresponding wildtype (WT) controls underwent reperfused myocardial infarction protocols. Surprisingly, reduced collagen deposition in Smad3 −/− infarcts was associated with increased infiltration with myofibroblasts. In vitro studies demonstrated that TGF-β1 inhibited murine cardiac fibroblast proliferation; these anti-proliferative effects were mediated via Smad3. Smad3 −/− fibroblasts were functionally defective, exhibiting impaired collagen lattice contraction when compared to wildtype cells. Decreased contractile function was associated with attenuated TGF-β-induced expression of α-smooth muscle actin. In addition, Smad3 −/− fibroblasts had decreased migratory activity upon stimulation with serum, and exhibited attenuated TGF-β-induced upregulation of extracellular matrix protein synthesis. Upregulation of connective tissue growth factor (CTGF), an essential downstream mediator in TGF-β-induced fibrosis, was in part dependent on Smad3. CTGF stimulation enhanced extracellular matrix protein expression by cardiac fibroblasts in a Smad3-independent manner. Disruption of Smad3 results in infiltration of the infarct with abundant, hypofunctional fibroblasts that exhibit impaired myofibroblast transdifferentiation, reduced migratory potential, and suppressed expression of fibrosis-associated genes.